StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$59.28−0.74 (-1.23%)

Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –

Ingevity operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ingevity's operating cash flow for the twelve months ending Jun 30, 2026 was $211.00M, down 2.0% year over year. For fiscal 2025 it was $331.20M, up 157.5% from the year before. Over ten years it grew 16.5% a year on average. The highest annual figure on record is $352.40M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$331.20M+157.5%
FY2024Dec 31, 2024$128.60M-37.3%
FY2023Dec 31, 2023$205.10M-34.6%
FY2022Dec 31, 2022$313.40M+6.9%
FY2021Dec 31, 2021$293.30M-16.8%
FY2020Dec 31, 2020$352.40M+27.8%
FY2019Dec 31, 2019$275.70M+9.4%
FY2018Dec 31, 2018$252.00M+44.6%
FY2017Dec 31, 2017$174.30M+36.3%
FY2016Dec 31, 2016$127.90M+77.1%
FY2015Dec 31, 2015$72.20M-47.9%
FY2014Dec 31, 2014$138.50M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.80M-117.5%
Q1 FY2026Mar 31, 2026-$2.00M-107.9%
Q4 FY2025Dec 31, 2025$97.10M+50.5%
Q3 FY2025Sep 30, 2025$129.70M+178.9%
Q2 FY2025Jun 30, 2025$79.00M+166.0%
Q1 FY2025Mar 31, 2025$25.40M–
Q4 FY2024Dec 31, 2024$64.50M+39.6%
Q3 FY2024Sep 30, 2024$46.50M-55.8%
Q2 FY2024Jun 30, 2024$29.70M-38.6%
Q1 FY2024Mar 31, 2024-$12.10M-328.3%
Q4 FY2023Dec 31, 2023$46.20M-53.1%
Q3 FY2023Sep 30, 2023$105.20M+5.1%
Q2 FY2023Jun 30, 2023$48.40M-46.5%
Q1 FY2023Mar 31, 2023$5.30M-78.2%
Q4 FY2022Dec 31, 2022$98.50M+29.1%
Q3 FY2022Sep 30, 2022$100.10M0.0%
Q2 FY2022Jun 30, 2022$90.50M+37.5%
Q1 FY2022Mar 31, 2022$24.30M-52.4%
Q4 FY2021Dec 31, 2021$76.30M-50.2%
Q3 FY2021Sep 30, 2021$100.10M+11.2%
Q2 FY2021Jun 30, 2021$65.80M+34.6%
Q1 FY2021Mar 31, 2021$51.10M-15.1%
Q4 FY2020Dec 31, 2020$153.30M+79.3%
Q3 FY2020Sep 30, 2020$90.00M-24.2%
Q2 FY2020Jun 30, 2020$48.90M-38.5%
Q1 FY2020Mar 31, 2020$60.20M–
Q4 FY2019Dec 31, 2019$85.50M-0.1%
Q3 FY2019Sep 30, 2019$118.70M+24.6%
Q2 FY2019Jun 30, 2019$79.50M+29.5%
Q1 FY2019Mar 31, 2019-$8.00M-182.5%
Q4 FY2018Dec 31, 2018$85.60M+110.3%
Q3 FY2018Sep 30, 2018$95.30M+17.8%
Q2 FY2018Jun 30, 2018$61.40M+32.9%
Q1 FY2018Mar 31, 2018$9.70M+49.2%
Q4 FY2017Dec 31, 2017$40.70M-24.3%
Q3 FY2017Sep 30, 2017$80.90M+113.5%
Q2 FY2017Jun 30, 2017$46.20M–
Q1 FY2017Mar 31, 2017$6.50M–
Q4 FY2016Dec 31, 2016$53.80M–
Q3 FY2016Sep 30, 2016$37.90M–

More Ingevity figures

See a number that looks wrong?